Deborah Daccord discusses the regulatory complexities and community based issues involved in substance use disorder and opioid addiction treatment center transactions as well as the uptick in investor interest in alternative prevention and treatment models.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
